Synthesis of some novel 1-(2-naphthyl)-2-(imidazol-1-yl)ethanone oxime ester derivatives and evaluation of their anticonvulsant activity
dc.authorid | alagoz, mehmet abdullah/0000-0001-5190-7196 | |
dc.authorid | Karakurt, Arzu/0000-0003-2209-0871 | |
dc.authorwosid | alagoz, mehmet abdullah/W-7847-2018 | |
dc.authorwosid | Karakurt, Arzu/ABH-9340-2020 | |
dc.contributor.author | Karakurt, Arzu | |
dc.contributor.author | Alagoz, Mehmet A. | |
dc.contributor.author | Sayoglu, Burcu | |
dc.contributor.author | Calis, Unsal | |
dc.contributor.author | Dalkara, Sevim | |
dc.date.accessioned | 2024-08-04T20:36:10Z | |
dc.date.available | 2024-08-04T20:36:10Z | |
dc.date.issued | 2012 | |
dc.department | İnönü Üniversitesi | en_US |
dc.description.abstract | Twenty-three new oxime ester derivatives of nafimidone were synthesized with the prospect of potential anticonvulsant activities. MES and ScM tests were employed for their anticonvulsant activities and rotorod test for neurological deficits. Eighteen compounds were found to be protective against MES seizures. Alkyl (1-8) and arylalkyl (9,10) oxime ester derivatives were found to be more active than aryl oxime ester derivatives (11-23). Five compounds (2, 3, 7, 9, 10), which were protective at 0.5 h at the doses of 30 mg/kg and higher in MES test, showed the highest activity. Compound 17 was the most active one in ScM test at all dose levels at 4 h. (C) 2012 Elsevier Masson SAS. All rights reserved. | en_US |
dc.description.sponsorship | Hacettepe University Scientific Research Fund [06 D03 301 001]; TUBITAK [110S270]; Inonu University Scientific Researches Unit [2011/66] | en_US |
dc.description.sponsorship | This project was supported by Hacettepe University Scientific Research Fund, (Project no: 06 D03 301 001), TUBITAK, (Project no: 110S270) and Inonu University Scientific Researches Unit (Project no: 2011/66). | en_US |
dc.identifier.doi | 10.1016/j.ejmech.2012.08.037 | |
dc.identifier.endpage | 282 | en_US |
dc.identifier.issn | 0223-5234 | |
dc.identifier.pmid | 23085104 | en_US |
dc.identifier.scopus | 2-s2.0-84867433214 | en_US |
dc.identifier.scopusquality | Q1 | en_US |
dc.identifier.startpage | 275 | en_US |
dc.identifier.uri | https://doi.org/10.1016/j.ejmech.2012.08.037 | |
dc.identifier.uri | https://hdl.handle.net/11616/95819 | |
dc.identifier.volume | 57 | en_US |
dc.identifier.wos | WOS:000312621700029 | en_US |
dc.identifier.wosquality | Q1 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Elsevier France-Editions Scientifiques Medicales Elsevier | en_US |
dc.relation.ispartof | European Journal of Medicinal Chemistry | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Oxime ester | en_US |
dc.subject | (arylalkyl)imidazole | en_US |
dc.subject | Azole derivatives | en_US |
dc.subject | Anticonvulsant activity | en_US |
dc.subject | E/Z isomers | en_US |
dc.title | Synthesis of some novel 1-(2-naphthyl)-2-(imidazol-1-yl)ethanone oxime ester derivatives and evaluation of their anticonvulsant activity | en_US |
dc.type | Article | en_US |